Technology
Executives weigh in on current valuations and hype around AI in the healthcare sector and what it could mean for the future.
Virtual pediatric care company Clarity Pediatrics garners $14.5 million to expand into obesity care.
A handful of transformative transactions lifted 2025 merger and acquisitions totals, but dealmakers largely remained disciplined, prioritizing data-driven growth and digital platforms.
The company will use the funds to accelerate commercialization of its brain-signal AI technology and expand its cognitive health applications.
Next year, AI will move beyond administrative support to become a workflow-integrated tool that drives predictive and proactive care and sees true adoption, according to healthcare leaders.
Also, University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of Alzheimer's disease in a world's first in-human trial.
Next year will mark a turning point for AI in healthcare as the industry shifts from pilots and hype to accountable, integrated systems that prove to have measurable impact, according to execs.
AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.
Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic disease risk and aging.
The federal grants will support CranioSense’s development and validation of its non-invasive intracranial pressure monitoring device.